1536695247241109506

As #EHA2022 ends, Gamida Cell continues to advance its unique curative approach with #NAMenabled cell therapy candidates as a potential new treatment for patients with hematologic and solid tumor cancers. https://t.co/dAmSq1l24z
#StemCellTherapy
#NKCellTherapy
#BloodCancers https://t.co/eU5YpEQLoK

Send us a message